Ads
related to: medications that increase oxygen
Search results
Results From The WOW.Com Content Network
Oxygen diffusion-enhancing compounds have shown promise in the treatment of conditions associated with hypoxia (a lack of oxygen in tissues) and ischemia (a lack of oxygen in the circulating blood supply). [1] [2] Such conditions include hemorrhagic shock, myocardial infarction (heart attack), and stroke. [2]
Hyperbaric medicine includes hyperbaric oxygen treatment, which is the medical use of oxygen at greater than atmospheric pressure to increase the availability of oxygen in the body; [8] and therapeutic recompression, which involves increasing the ambient pressure on a person, usually a diver, to treat decompression sickness or an air embolism by reducing the volume and more rapidly eliminating ...
[2] [7] Higher oxygen concentrations can also increase the risk of airway fires, particularly while smoking. [1] Oxygen therapy can also dry out the nasal mucosa without humidification. [1] In most conditions, an oxygen saturation of 94–96% is adequate, while in those at risk of carbon dioxide retention, saturations of 88–92% are preferred.
Venous oxygen saturation (SvO 2) is the percentage of oxygenated hemoglobin returning to the right side of the heart. It can be measured to see if oxygen delivery meets the tissues' demands. SvO 2 typically varies between 60% and 80%. [9] A lower value indicates that the body is in lack of oxygen, and ischemic diseases occur.
Nitrous oxide, as medical gas supply, is an inhaled gas used as pain medication, and is typically administered with 50% oxygen mix. It is often used together with other medications for anesthesia. [2] Common uses include during childbirth, following trauma, and as part of end-of-life care. [2]
[19] [20] In cases where the oxygen tension at the mitochondria are very low, this would expose nearby red blood cells to lower oxygen tensions and cause them to offload more oxygen as described by the oxygen–hemoglobin dissociation curve. The most notable example is dodecafluoropentane emulsion (DDFPe, formerly EchoGen, now NanO 2). The drug ...